FYERS
Auro Laboratories254.55
+4.45 (+1.86%)

Auro Laboratories Share Price

254.55+4.45 (+1.86%)
+6.31% past 1 Year

Corporate filings & documents

Announcements

Auro Laboratories Limited has submitted the clippings of newspaper publications of the Un-audited Financial Results for the quarter ended June 30 2026.
1 month ago
Auro Laboratories Limited has submitted the clippings of newspaper publications of the Un-audited Financial Results for the quarter ended June 30 2026.
1 month ago
Auro Laboratories Limited has submitted the Unaudited Financial Results for the Quarter ended June 30 2026.
1 month ago
Auro Laboratories Limited has submitted the Unaudited Financial Results for the Quarter ended June 30 2026.
1 month ago
Auro Laboratories Limited has submitted the Outcome of the Board Meeting held on August 14 2026
1 month ago
Auro Laboratories Limited has submitted the Outcome of the Board Meeting held on August 14 2026
1 month ago
Auro Laboratories Limited has submitted the Scrutinizer Report of 37th AGM held on August 11 2026.
1 month ago
Auro Laboratories Limited has submitted the Scrutinizer Report of 37th AGM held on August 11 2026.
1 month ago
Auro Laboratories Limited has submitted the Proceedings/Outcome of the 37th Annual General Meeting held on August 11 2026.
1 month ago
Auro Laboratories Limited has submitted the Proceedings/Outcome of the 37th Annual General Meeting held on August 11 2026.
1 month ago
Auro Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Unaudited Financial Results for the Quarter ended 30 June 2026 and any other matter with the permission of the chair.
1 month ago
Auro Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Unaudited Financial Results for the Quarter ended 30 June 2026 and any other matter with the permission of the chair.
1 month ago
With reference to Regulation 47 of SEBI (LODR) Regulations 2015 attached herewith newspaper cuttings of Public Notice of the 37th AGM information on evoting and other related information.
2 months ago
With reference to Regulation 47 of SEBI (LODR) Regulations 2015 attached herewith newspaper cuttings of Public Notice of the 37th AGM information on evoting and other related information.
2 months ago
The Letter being send to the shareholders containing the web-link of the Annual Report of the Company for the FY 2025-2026 is enclosed.
2 months ago
The Letter being send to the shareholders containing the web-link of the Annual Report of the Company for the FY 2025-2026 is enclosed.
2 months ago
Enclosed Annual report of the Company for the FY 2025-2026
2 months ago
Enclosed Annual report of the Company for the FY 2025-2026
2 months ago
Enclosed Notice of 37th Annual General Meeting of the Company scheduled on August 11 2026 at 11:30a.m. (IST)
2 months ago
Enclosed Notice of 37th Annual General Meeting of the Company scheduled on August 11 2026 at 11:30a.m. (IST)
2 months ago
Auro Laboratories Limited has submitted the Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 30 2026.
2 months ago
Auro Laboratories Limited has submitted the Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 30 2026.
2 months ago
Auro Laboratories Limited has submitted the Newspaper Publication regarding intimation of 37th AGM of the Company.
2 months ago
Auro Laboratories Limited has submitted the Newspaper Publication regarding intimation of 37th AGM of the Company.
2 months ago
Auro Laboratories Limited hereby approve the re-appointment of Mr. Kiran Suresh Kulkarni as a Whole Time Director.
2 months ago
Auro Laboratories Limited hereby approve the re-appointment of Mr. Kiran Suresh Kulkarni as a Whole Time Director.
2 months ago
Auro Laboratories Limited scheduled the Board Meeting on June 30 2026 to transact the business matter which are attached herewith.
2 months ago
Auro Laboratories Limited scheduled the Board Meeting on June 30 2026 to transact the business matter which are attached herewith.
2 months ago
Auro Laboratories Limited has informed about the Closure of Trading Window.
2 months ago
Auro Laboratories Limited has informed about the Closure of Trading Window.
2 months ago
Enclosed herewith Newspaper Advertisement
3 months ago
Enclosed herewith Newspaper Advertisement
3 months ago
Enclosed herewith Annual Secretarial Compliance Report for the Year Ended March 31 2026.
3 months ago
Enclosed herewith appointment of Chief Financial Officer Tax Auditor Internal Auditor and Reappointment of Cost Auditor.
3 months ago
Enclosed herewith appointment of Chief Financial Officer Tax Auditor Internal Auditor and Reappointment of Cost Auditor.
3 months ago
Enclosed herewith Financial Results for the year ended March 31 2026
3 months ago
Enclosed herewith Financial Results for the year ended March 31 2026
3 months ago
Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors of the Company at their meeting held today i.e. May 29 2026 inter-alia considered the matters as enclosed herewith.
3 months ago
Auro Laboratories Limited has submitted the Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015 for Resignation of Mr. Kuntal Pancholi as the Chief Financial Officer & Key Managerial Personnel of the Company w.e.f May 28 2026.
3 months ago
Auro Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve Audited Financial Results of the Company along with Report of the Auditors for the Quarter and Year Ended March 31 2026 and any other matter with the permission of the Chair.
4 months ago
Auro Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve Audited Financial Results of the Company along with Report of the Auditors for the Quarter and Year Ended March 31 2026 and any other matter with the permission of the Chair.
4 months ago
Auro Laboratories Limited submits that the Company has received a "Certification of Substances Department" from the European Directorate for the Quality of Medicines & Healthcare ("EDQM") for the Companys Manufacturing facility situated at M.I.D.C Tarapur Maharashtra.
4 months ago
Auro Laboratories Limited submits that the Company has received a Certificate of GMP Compliance of a Manufacturer from Swissmedic Swiss Agency for Therapeutic Products for the Companys manufacturing facility situated at M.I.D.C Tarapur Maharashtra.
4 months ago
Auro Laboratories Limited has submitted the Disclosure in relation to Credit Rating obtained by the Company from Acuite Ratings & Research Limited.
5 months ago
Auro Laboratories Limited has submitted the Disclosure in relation to Credit Rating obtained by the Company from Acuite Ratings & Research Limited.
5 months ago
Auro Laboratories Limited has submitted the Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended March 31 2026.
5 months ago
Intimation for Closure of Trading Window
6 months ago
Intimation for Closure of Trading Window
6 months ago
Auro Laboratories Limited has submitted the clippings of Newspaper Publication of the Unaudited Financial Results of the Quarter and Nine Months ended December 31 2025.
7 months ago
Auro Laboratories Limited has submitted Financial Results for the quarter ended December 31 2025.
7 months ago

Annual reports

FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21

Concalls & investor presentations

Empty box

No presentations found

Auro Laboratories Ltd Share Price Today

The Auro Laboratories Ltd share price today is ₹255.00. During the trading session, the Auro Laboratories Ltd share price opened at ₹255.00 and recorded an intraday high of ₹257.00 and a low of ₹249.75. Last closing price was ₹256.90. Over the past 52 weeks, the Auro Laboratories Ltd share price has ranged between ₹159.00 and ₹317.00. The current Auro Laboratories Ltd stock price reflects real-time market activity based on executed trades on the exchange.